UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

M-IV Anti-viral resistance testing in hepatitis B virus infection

Journal of clinical virology, 2009-09, Vol.46, p.S3-S3

Bozdayi, M

2009

Volltextzugriff (PDF)

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome

Liver international, 2012-10, Vol.32 (9), p.1415-1425

2012

Volltextzugriff (PDF)

Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients

Archives of virology, 2004-11, Vol.149 (11), p.2115-2129

2004

Volltextzugriff (PDF)

Value of non-invasive fibrosis markers in chronic hepatitis D

Journal of hepatology, 2017, Vol.66 (1), p.S473-S473

2017

Volltextzugriff (PDF)

The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

Journal of hepatology, 2017, Vol.66 (1), p.S259-S259

2017

Volltextzugriff (PDF)

A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

Journal of hepatology, 2017, Vol.66 (1), p.S33-S34

2017

Volltextzugriff (PDF)

Natural history and treatment of chronic delta hepatitis

Journal of viral hepatitis, 2010-11, Vol.17 (11), p.749-756

2010

Volltextzugriff (PDF)

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

Journal of viral hepatitis, 2012-03, Vol.19 (3), p.220-226

2012

Volltextzugriff (PDF)

O118 : Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis

Journal of hepatology, 2015-04, Vol.62, p.S252-S252

2015

Volltextzugriff (PDF)

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

Journal of viral hepatitis, 2005-05, Vol.12 (3), p.262-268

2005

Volltextzugriff (PDF)

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis

European journal of gastroenterology & hepatology, 2005-03, Vol.17 (3), p.339-343

2005

Volltextzugriff (PDF)

Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines

Archives of virology, 2007-05, Vol.152 (5), p.871-879

2007

Volltextzugriff (PDF)

Cytotoxic CD4+ T cells in viral hepatitis

Journal of viral hepatitis, 2006-08, Vol.13 (8), p.505-514

2006

Volltextzugriff (PDF)

Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta

Journal of viral hepatitis, 2014-04, Vol.21 (4), p.297-304

2014

Volltextzugriff (PDF)

Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon‐alpha treatment for hepatitis C virus infection

Journal of the European Academy of Dermatology and Venereology, 2006-04, Vol.20 (4), p.442-445

2006

Volltextzugriff (PDF)

PS-161 - Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads

Journal of hepatology, 2018-04, Vol.68, p.S89-S89

2018

Volltextzugriff (PDF)

Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads

Journal of hepatology, 2018-04, Vol.68, p.S89

2018

Volltextzugriff (PDF)

FRI-142 - Value of non-invasive fibrosis markers in chronic hepatitis D

Journal of hepatology, 2017, Vol.66 (1), p.S473-S473

2017

Volltextzugriff (PDF)

[498] HIGH BASELINE HBV-DNA IS LINKED TO THE EMERGENCE OF ADEFOVIR RESISTANCE IN LAMIVUDINE RESISTANT PATIENTS

Journal of hepatology, 2007, Vol.46, p.S189-S190

2007

Volltextzugriff (PDF)

Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease

Hepato-gastroenterology, 2000-11, Vol.47 (36), p.1675

2000

Volltextzugriff (PDF)

GS-008 - A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

Journal of hepatology, 2017, Vol.66 (1), p.S33-S34

2017

Volltextzugriff (PDF)

THU-161 - The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

Journal of hepatology, 2017, Vol.66 (1), p.S259-S259

2017

Volltextzugriff (PDF)

Entecavir Treatment of Chronic Hepatitis D

Clinical infectious diseases, 2012-09, Vol.55 (5), p.645-650

2012

Volltextzugriff (PDF)

Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats

Human & experimental toxicology, 1999-11, Vol.18 (11), p.669-676

1999

Volltextzugriff (PDF)

Polymorphism of precore region of hepatitis B virus DNA among patients with chronic HBV infection in Turkey

Infection, 1999-11, Vol.27 (6), p.357-360

1999

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Englisch
(107)
Deutsch
(1)
Türkisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

M-IV Anti-viral resistance testing in hepatitis B virus infection

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome

Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients

Value of non-invasive fibrosis markers in chronic hepatitis D

The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

Natural history and treatment of chronic delta hepatitis

Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients

O118 : Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis

Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines

Cytotoxic CD4+ T cells in viral hepatitis

Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta

Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon‐alpha treatment for hepatitis C virus infection

PS-161 - Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads

Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads

FRI-142 - Value of non-invasive fibrosis markers in chronic hepatitis D

[498] HIGH BASELINE HBV-DNA IS LINKED TO THE EMERGENCE OF ADEFOVIR RESISTANCE IN LAMIVUDINE RESISTANT PATIENTS

Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease

GS-008 - A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

THU-161 - The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

Entecavir Treatment of Chronic Hepatitis D

Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats

Polymorphism of precore region of hepatitis B virus DNA among patients with chronic HBV infection in Turkey

Suchergebnisse filtern